Archive · 26 Oct 2025
Mukul Agrawal Invests in Kilitch Drugs India: Key Details
Imagine a famous investor named Mukul Agrawal, who likes to pick stocks.
He just bought a part of a company called Kilitch Drugs India!
This company makes medicines.
Mukul bought about 1.3% of the company, which cost him around ₹90 million.
The company is doing well; their sales and profits went up a lot!
Also, the company is building a new factory in Maharashtra to make more medicines.
Because the company is doing well, Mukul may have chosen to invest in the company.
But before you also invest, it's wise to do your own research.
Mukul Agrawal acquired a stake in Kilitch Drugs India.
Agrawal's stake represents 1.3% of the company's shares, valued at about ₹90 million.
Kilitch Drugs India reported significant growth in sales (29% YoY) and net profit (2,200% YoY).
The company is expanding with a new ₹1,600 million project in Pen, Maharashtra.
Kilitch Drugs India manufactures a wide range of pharmaceutical products.
- Who
- Mukul Agrawal
- What
- Purchased a stake in Kilitch Drugs India
- When
- As of the end of the September 2025 quarter
- Where
- Not explicitly mentioned
- Why
- Improving financials and company expansion
- Investor
- Mukul Agrawal
- Stock
- Kilitch Drugs India
- Stake
- 1.3% (approx. ₹90 million)
- Quarterly Sales Increase
- 29% YoY
- Quarterly Net Profit Increase
- 2,200% YoY
- New Project Location
- Pen, Maharashtra
- Project Investment
- ₹1,600 million
- Product Portfolio
- Pharmaceutical formulations (tablets, capsules, injectables, etc.)
